chromosome

trends & perspectives in clinical research

goBalto Chromosome

Webinar: Eliminating the Three Evil E's in Study Startup

by Craig Morgan
16Jan2017

Save your seat for this upcoming webinar! A paradigm shift is needed in order to eliminate the three evil "e's" – email, Excel, and e-meetings – long associated with starting clinical trials.

Webinar: Eliminating the Three Evil E's in Study Startup

Title: Eliminating the Three Evil E's in Study Startup

Description:

In an effort to confront the oft-mentioned costs of drug development, the clinical trials industry has been evolving from its slow paper-based methods and standalone spreadsheets towards automated, cloud-based systems. There has always been a strong focus on study conduct and quality. But as stakeholders are increasingly aware that better study startup (SSU) processes are linked to shorter clinical timelines, the emphasis is shifting in that direction. A paradigm shift is needed in order to eliminate the three evil "e's" – email, Excel, and e-meetings – long associated with starting clinical trials, with the potential to ultimately reduce timelines and improve data quality. The webinar will focus on addressing the inefficiencies associated with the three evil "e's".

In this webinar we will explore:

  • Improving operational performance with intelligent document routing and milestone planning
  • Ensuring regulatory/SOP compliance (e.g., Clinical Trial Regulation EU No. 536/2014)
  • Continuity of service with role management and alerts
  • Empowering risk management with real-time reporting

This webinar is applicable to:

  • Sponsor and CRO roles responsible for site selection and activation
  • Sponsor and CRO roles responsible for collecting and evaluating trial metrics

When:

Tuesday, January 31
1 pm ET
10 am PT

Save my seat

Presenters:

Barry Milton
BARRY MILTON
Head of Business Operations
Novartis
Barry is a clinical trial and operations management expert. His experiences as an Oncology nurse, clinical trial coordinator and his senior management roles at Novartis, Roche, Merck, and AstraZeneca provides him with a well-rounded set of skills and experiences in the clinical trial space.
Jaime Lau
JAIME LAU
Director, Product Management
goBalto
Jaime is a clinical trial and innovative product strategist, experienced in building, evolving and implementing market-leading technology solutions for many of the world's leading pharmaceutical, biotech, research and medical device organizations. Her passion is transforming study management and trial execution processes through the creation of optimized business processes, which are supported by facilitating systems – allowing sponsor and investigator teams to meet their patient and clinical program goals faster and more efficiently.

Recent Posts